Combination index of the concentration and in vivo antagonism activity of racemic warfarin and its metabolites to assess individual drug responses
Combination index of the concentration and in vivo antagonism activity of racemic warfarin and its metabolites to assess individual drug responses
复制标题
外消旋华法林及其代谢物的浓度和体内拮抗活性的组合指数评估个体药物反应
DOI:
10.1007/s11239-018-1780-5
复制
发表时间:
2018
影响因子:
4
通讯作者:
Ohyama Kaname
中科院分区:
文献类型:
--
作者:
Kobayashi Shuhei;Ishii Koji;Yamada Yasuko;Ryu Emi;Hashizume Junya;Nose Seiichi;Hara Tetsuya;Nakashima Mikiro;Ohyama Kaname
The present study was undertaken to examine whether in vivo vitamin K epoxide reductase complex 1 (VKOR) “actual” antagonism activity, calculated by the concentrations and the reported anticoagulant activities of theR- andS-warfarin enantiomers and their metabolites, correlates with the weekly dose of warfarin. Five patients under palliative care were enrolled in our study and 20 serum samples were analyzed by an enantioselective high-performance liquid chromatography–ultraviolet detection method. In vivo VKOR inhibition activities ofS-warfarin,R-warfarin, 7- and 10-hydroxywarfarin were calculated as the ratio of drug or metabolite concentration to the IC50. The mean drug concentrations (± SD) ofS- andR-warfarin, 7-hydroxywarfarin and 10-hydroxywarfarin were 334 ± 154 ng/ml, 370 ± 115 ng/ml, 42 ± 15 ng/ml and 80 ± 44 ng/ml, respectively. Then, in vivo VKOR actual antagonism activities ofS- andR-warfarin, 7-hydroxywarfarin and 10-hydroxywarfarin were calculated. Good correlation (R2= 0.69–0.72) was obtained between the weekly warfarin dose and the ratios of INR/actual antagonism activity, while poor correlation was observed between the weekly warfarin dose and INR (R2= 0.32) or the activities (R2= 0.17–0.21). Actual antagonism activities along with the INR correlated well with the warfarin dose. This parameter may be useful for predicting or altering warfarin doses, although further verification in a larger study is required.
登录
查看更多内容
DOI:
10.1056/nejmoa1310669
发表时间:
2013-12-12
期刊:
The New England journal of medicine
影响因子:
--
作者:
Kimmel SE;French B;Kasner SE;Johnson JA;Anderson JL;Gage BF;Rosenberg YD;Eby CS;Madigan RA;McBane RB;Abdel-Rahman SZ;Stevens SM;Yale S;Mohler ER 3rd;Fang MC;Shah V;Horenstein RB;Limdi NA;Muldowney JA 3rd;Gujral J;Delafontaine P;Desnick RJ;Ortel TL;Billett HH;Pendleton RC;Geller NL;Halperin JL;Goldhaber SZ;Caldwell MD;Califf RM;Ellenberg JH;COAG Investigators
通讯作者:
COAG Investigators
影响因子:
7.5
作者:
Odén, A;Fahlén, M;Hart, RG
通讯作者:
Hart, RG
DOI:
10.1016/j.chroma.2014.08.025
发表时间:
2014
期刊:
Journal of chromatography. A
影响因子:
--
作者:
E. Regalado;J. Schariter;C. Welch
通讯作者:
C. Welch
影响因子:
5.8
作者:
Yamazaki, H;Shimada, T
通讯作者:
Shimada, T
影响因子:
2.6
作者:
Takahashi, Harumi;Wilkinson, Grant R.;Echizen, Hirotoshi
通讯作者:
Echizen, Hirotoshi